Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s footer revision/version indicator was incremented from **v3.5.2** to **v3.5.3**, reflecting a site/record interface update rather than a change to the clinical trial details.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No substantive content changes are visible.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a new site revision note: v3.4.2. The notices about government funding lapse and the older revision v3.4.1 were removed.SummaryDifference0.4%

- Check91 days agoChange DetectedThe page now includes a government funding lapse notice and a new revision label v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.